ANOVA test results of 12 and 15 Gy compared to sham-CTRL group.
收藏NIAID Data Ecosystem2026-03-11 收录
数据链接：
官方服务：
资源简介：
ANOVA test results of 12 and 15 Gy compared to sham-CTRL group.
应用场景：
创建时间：
2020-05-22
相关数据集
ANOVA test results of 17 and 19 Gy compared to sham-CTRL group.
ANOVA test results of 17 and 19 Gy compared to sham-CTRL group.
NIAID Data Ecosystem40
Effect of changing the radiation dose range on the in vitro cytogenetic dose response to gamma-rays
To examine the distortion of the linear quadratic (LQ) model of in vitro cytogenetic dose response over an extended range of γ-ray doses by analyzing the available literature data, and to establish th
DataCite Commons2025-06-30 更新40
Excess relative risk per dose for external gamma radiation for various lag-times.
Excess relative risk per dose () with 95% confidence levels. The LNT model was applied using various lag-times. Deviances () are compared to the analysis with a lag-time of ten years.
NIAID Data Ecosystem20
Average individual detriment accumulated over 70 y for a resident living in an area affected by a Chernobyl-like NPP remote fallout for newborns and 30 y olds. Detriments are given in terms of cumulative effective dose, CED (70 y), attributed detriment using the ICRP (2007) risk coefficients for members of the public (0.05 Sv -1 ), and cumulative lifetime attributable risk of cancer (excluding non-fatal skin cancers) incidence, CUMLAR WB (70 y), for three scenarios described in Table 5.
Average individual detriment accumulated over 70 y for a resident living in an area affected by a Chernobyl-like NPP remote fallout for newborns and 30 y olds. Detriments are given in terms of cumulat
NIAID Data Ecosystem40
Data for: Dose response analysis program (DREAP): a user-friendly program for the analyses of radiation-induced biological responses utilizing established deterministic models at cell population and organ scales.
DREAP stands for dose response analysis program, a user-friendly program for analysis of radiation-induced biological responses such as survival fraction, relative biological effectiveness, normal tis
NIAID Data Ecosystem30
